Skip to Main Content

Paper Details

BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation.
Proc Natl Acad Sci U S A
16
2018
AKT, BRCA1, BRCA1 product, GSK-3, HIF-1, IRIS, PI3K, PTEN, acute myeloid leukemia, breast and ovarian tumor, breast cancer, cancer, carcinomas, human, human cancer cells, lung cancer, mouse, patient, patient-derived xenograft (PDX) cells, phosphatase and tensin homolog, prolyl, prolyl hydroxylase, tumor
Author NameAffiliation
Aedin C CulhaneDana-Farber Cancer Institute
Aedin C CulhaneHarvard T. H. Chan School of Public Health
Aedin C CulhaneDana-Farber Cancer Institute
Aedin C CulhaneHarvard T. H. Chan School of Public Health
Kimberly J BriggsDana-Farber Cancer Institute
Jean J ZhaoDana-Farber Cancer Institute
Jean J ZhaoHarvard Medical School
  • 1 - 7

Datasets

Release 1.2